Jam

South Bow (SOBO) will release Q2 2025 financial results after markets close on August 6, 2025. An earnings call follows on August 7th at 8:00 AM MT. The pure-play pipeline operator’s performance, particularly terminal utilization and tolling agreements, is watched amid sector scrutiny over regulations and volatile markets. Management will address operational efficiency, regulatory challenges, and commercial resilience of its key Alberta-U.S. crude oil network.

Shareholders of Till Capital approved Silver Storm Mining’s acquisition deal on July 10, 2025. The court-supervised transaction requires final approvals from the B.C. Supreme Court (hearing July 15) and TSX-V to close around July 17. This expands Silver Storm’s Mexican silver assets, primarily the past-producing La Parrilla Complex. Reactivating La Parrilla relies on historical data, not updated feasibility studies, increasing operational uncertainty. Completion remains contingent on court and exchange approvals.

SeaStar Medical raised $4M through a registered direct offering of 5.24 million shares priced at $0.763 each, with five-year warrants exercisable at $0.638. The capital infusion supports commercialization of its FDA-approved pediatric AKI device and adult trials, but triggers 33% equity dilution. Analysts note the structure creates potential stock price pressure, as warrants priced 16% below offering prices might constrain valuations. While addressing immediate liquidity needs, the conventional equity approach suggests urgency in funding operations rather than strategic growth initiatives, with funds allocated vaguely for corporate purposes.

Fetner Properties, MCB Real Estate, and Farallon Capital acquired Brooklyn’s new 240 Willoughby Street, a $209.5 million, 463-unit luxury tower. Featuring mixed-income housing (147 income-restricted units), the building boasts panoramic Fort Greene Park and Manhattan skyline views. Its premium amenities include coworking spaces, a biometric gym, and entertainment suites. Demand is strong with 25% leased since opening, reflecting Brooklyn’s appetite for resort-style urban living. Studios start at $3,200/month, positioning the transit-proximate development competitively.

Century Communities launched Windler, a new single-family home community in Aurora, Colorado. The development features over 130 homes across four distinct floor plan collections, sizes ranging from 1,305 to 2,365 sq ft. It offers major amenities on 160 acres of parks, trails, sports courts, a clubhouse, and pool. Strategically located near Denver, Windler emphasizes modern design integrating with nature and flexible online homebuying. A grand opening celebration is scheduled for July 12, 2025.

MTM Critical Metals Ltd (rebranding as Metallium Ltd) has moved to the premium OTCQX Market, enhancing its US presence for investors. This upgrade supports its expansion, including a $50 million capital raise and constructing its first Flash Joule Heating facility in Texas. The proprietary technology recovers critical metals sustainably from waste and concentrates. This positions the company to meet demand in semiconductors and clean energy while aligning with decarbonization goals.

Silver47 Exploration (AAGAF) is finalizing its 2025 exploration program at British Columbia’s Adams Plateau Project, targeting SEDEX silver-zinc-copper-gold-lead deposits. Collecting 5,008 soil and 76 rock samples revealed high-grade results, including recent surface samples up to 3,503 g/t Ag and historic intercepts of 4.8m @ 348 g/t Ag. The consolidated 150 km² property unifies 25+ mineral occurrences under a new 5-year permit, supported by robust infrastructure. While surface data highlights district-scale potential, challenges include verification of historical drill records and limited exploration continuity beyond known zones.

Klotho Neurosciences received FDA Orphan Drug Designation for ALS therapy candidate KLTO-202, granting tax benefits, fee exemptions, and potential 7-year U.S. exclusivity. The gene therapy targets neuromuscular junctions via a proprietary delivery system to combat motor neuron degradation while enhancing protective protein expression. CEO Joseph Sinkule emphasized its scientific promise against ALS, which affects under 200,000 Americans annually with no cure. Following animal model successes, Klotho progresses manufacturing development and regulatory plans. The investigational treatment forms part of its pipeline targeting neurodegenerative diseases through its s-KL protein platform.

E3 Lithium Ltd. delivered key Direct Lithium Extraction (DLE) equipment, including a 30-column system, to its Clearwater Project demonstration site. This milestone advances the vital Canadian lithium project toward validation of its process. Initial operations will test equipment and aim to produce battery-grade lithium carbonate. CEO Chris Doornbos states this moves pilot results toward commercial scale, highlighting Canada’s strategic lithium supply potential. The project leverages Alberta’s significant 21.2 million tonne lithium resource base.

Pony AI has initiated mass production of its seventh-generation robotaxi platform through partnerships with GAC (June 2025) and BAIC (July 2025), advancing commercialization. The new system achieves full automotive-grade component certification, reduces autonomous hardware costs by 70%, and features scalable architecture for cross-vehicle adaptation. Targeting deployment of 1,000 operational vehicles globally by late 2025, the company is conducting extensive road testing in Guangzhou and Shenzhen. These advancements position Pony AI to overcome scalability barriers and set industry benchmarks for cost-efficient autonomous fleet deployment.